Overview

Rate Control in Patients With Atrial Fibrillation

Status:
Not yet recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
To search for the best marker for the patients in atrial fibrillation with rate control
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Atenolol
Bisoprolol
Digoxin
Diltiazem
Metoprolol
Nebivolol
Propranolol
Verapamil